NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Press Enter or click the Search button to begin your search.

Back to Results
A Multiple Parameters Biodosimetry Tool with Various Blood Cell Counts - the Hemodose ApproachThere continue to be important concerns about the possibility of the occurrence of acute radiation syndromes following nuclear and radiological terrorism or accidents that may result in mass casualties in densely populated areas. To guide medical personnel in their clinical decisions for effective medical management and treatment of the exposed individuals, biological markers are usually applied to examine radiation induced biological changes to assess the severity of radiation injury to sensitive organ systems. Among these the peripheral blood cell counts are widely used to assess the extent of radiation induced bone marrow injury. This is due to the fact that the hematopoietic system is the most vulnerable part of the human body to radiation damage. Particularly, the lymphocyte, granulocyte, and platelet cells are the most radiosensitive of the blood elements, and monitoring their changes after exposure is regarded as a practical and recommended laboratory test to estimate radiation dose and injury. Based upon years of physiological and pathophysiological investigation of mammalian hematopoietic systems, and rigorous coarse-grained bio-mathematical modeling and validation on species from mouse, to dog, monkey, and human, we have developed a set of software tools Hemodose, which can use single or serial granulocyte, lymphocyte, leukocyte, or platelet counts after exposure to estimate absorbed doses of adult victims very rapidly and accurately. Some patient data from historical accidents are utilized as examples to demonstrate the capabilities of these tools as a rapid point-of-care diagnostic or centralized high-throughput assay system in a large-scale radiological disaster scenario. Most significant to the improvement of national and local preparedness of a potential nuclear/radiological disaster, this HemoDose approach establishes robust correlations between the absorbed doses and victim's various types of blood cell counts not only in the early time window (1 or 2 days), but also in the very late phase (up to 4 weeks) after exposure.
Document ID
20140013076
Acquisition Source
Johnson Space Center
Document Type
Abstract
Authors
Hu, Shaowen
(Universities Space Research Association Houston, TX, United States)
Date Acquired
October 16, 2014
Publication Date
September 21, 2014
Subject Category
Aerospace Medicine
Report/Patent Number
JSC-CN-30755
Report Number: JSC-CN-30755
Meeting Information
Meeting: Annual Meeting of the Radiation Research Society
Location: Las Vegas NV
Country: United States
Start Date: September 21, 2014
End Date: September 24, 2014
Sponsors: Radiation Research Society
Distribution Limits
Public
Copyright
Public Use Permitted.
No Preview Available